America July 14, 2025
Waters, BD Unite in $17.5B Diagnostics Deal
In a strategic play poised to reshape the diagnostics and life sciences landscape, Waters Corp. and Becton Dickinson and Co.…
America July 14, 2025
In a strategic play poised to reshape the diagnostics and life sciences landscape, Waters Corp. and Becton Dickinson and Co.…
By Rihem Akkouche
America July 10, 2025
In a move that signals intensifying ambitions in the cancer therapeutics arena, pharmaceutical titan AbbVie Inc. unveiled Thursday a blockbuster…
By Rihem Akkouche
America June 18, 2025
Draig Therapeutics Ltd., a rising star in neuropsychiatric drug development, has closed a $140 million Series A financing round, the…
By Rihem Akkouche
America June 16, 2025
In a bold bid to dominate the neuropsychiatric treatment space, Supernus Pharmaceuticals Inc. announced Monday that it will acquire Sage…
By Rihem Akkouche
America June 12, 2025
In a bold move that could redefine the future of mRNA-driven cancer therapies, German biotech giant BioNTech SE announced Thursday…
By Rihem Akkouche
America June 10, 2025
In a dramatic twist in the biotech sector, a subsidiary of National Resilience Holdco Inc. has filed for Chapter 11…
By Rihem Akkouche
America June 2, 2025
In a bold stride toward strengthening its grip on the immunology and rare disease market, French pharmaceutical titan Sanofi SA…
By Rihem Akkouche
America May 8, 2025
In a dramatic turn for the embattled biotech sector, Accelerate Diagnostics, Inc. has voluntarily filed for Chapter 11 bankruptcy protection in…
By Rihem Akkouche
America March 25, 2025
Merck & Co. Inc. is making a high-stakes move in the cardiovascular drug market, announcing on Tuesday an exclusive licensing…
By Rihem Akkouche
America March 24, 2025
23andMe Inc., once a trailblazer in consumer DNA testing, has filed for Chapter 11 bankruptcy protection in Missouri court, marking…
By Rihem Akkouche